Study: NCT04204772

Adverse event: abdominal fullness/bloating
Serious: no
Organ System: Gastrointestinal disorders
Notes: AEs were all grade 1 and included abdominal fullness/bloating in 4 (33%) subjects, abdominal pain in 4 (33%) subjects, nausea in 2 (17%) subjects, constipation in 2 (17%) subjects, and diarrhea in 1 (8%) subject.
Frequency: 1 affected / 6 at risk

Adverse event: Nausea
Serious: no
Organ System: General disorders
Notes: AEs were all grade 1 and included abdominal fullness/bloating in 4 (33%) subjects, abdominal pain in 4 (33%) subjects, nausea in 2 (17%) subjects, constipation in 2 (17%) subjects, and diarrhea in 1 (8%) subject.
Frequency: 1 affected / 6 at risk

Adverse event: Constipation
Serious: no
Organ System: Gastrointestinal disorders
Notes: AEs were all grade 1 and included abdominal fullness/bloating in 4 (33%) subjects, abdominal pain in 4 (33%) subjects, nausea in 2 (17%) subjects, constipation in 2 (17%) subjects, and diarrhea in 1 (8%) subject.
Frequency: 1 affected / 6 at risk

Adverse event: Abdominal pain
Serious: no
Organ System: Gastrointestinal disorders
Notes: AEs were all grade 1 and included abdominal fullness/bloating in 4 (33%) subjects, abdominal pain in 4 (33%) subjects, nausea in 2 (17%) subjects, constipation in 2 (17%) subjects, and diarrhea in 1 (8%) subject.
Frequency: 1 affected / 6 at risk

Adverse event: Mild Throat Pain/dryness
Serious: no
Organ System: General disorders
Frequency: 1 affected / 6 at risk

Adverse event: abdominal fullness/bloating
Serious: no
Organ System: Gastrointestinal disorders
Notes: AEs were all grade 1 and included abdominal fullness/bloating in 4 (33%) subjects, abdominal pain in 4 (33%) subjects, nausea in 2 (17%) subjects, constipation in 2 (17%) subjects, and diarrhea in 1 (8%) subject.
Frequency: 1 affected / 6 at risk

Adverse event: Nausea
Serious: no
Organ System: General disorders
Notes: AEs were all grade 1 and included abdominal fullness/bloating in 4 (33%) subjects, abdominal pain in 4 (33%) subjects, nausea in 2 (17%) subjects, constipation in 2 (17%) subjects, and diarrhea in 1 (8%) subject.
Frequency: 1 affected / 6 at risk

Adverse event: Constipation
Serious: no
Organ System: Gastrointestinal disorders
Notes: AEs were all grade 1 and included abdominal fullness/bloating in 4 (33%) subjects, abdominal pain in 4 (33%) subjects, nausea in 2 (17%) subjects, constipation in 2 (17%) subjects, and diarrhea in 1 (8%) subject.
Frequency: 1 affected / 6 at risk

Adverse event: Mild Throat Pain/dryness
Serious: no
Organ System: General disorders
Frequency: 1 affected / 6 at risk

Adverse event: abdominal fullness/bloating
Serious: no
Organ System: Gastrointestinal disorders
Notes: AEs were all grade 1 and included abdominal fullness/bloating in 4 (33%) subjects, abdominal pain in 4 (33%) subjects, nausea in 2 (17%) subjects, constipation in 2 (17%) subjects, and diarrhea in 1 (8%) subject.
Frequency: 2 affected / 6 at risk

Adverse event: Abdominal pain
Serious: no
Organ System: Gastrointestinal disorders
Notes: AEs were all grade 1 and included abdominal fullness/bloating in 4 (33%) subjects, abdominal pain in 4 (33%) subjects, nausea in 2 (17%) subjects, constipation in 2 (17%) subjects, and diarrhea in 1 (8%) subject.
Frequency: 2 affected / 6 at risk

Adverse event: Diarrhoea
Serious: no
Organ System: Gastrointestinal disorders
Notes: AEs were all grade 1 and included abdominal fullness/bloating in 4 (33%) subjects, abdominal pain in 4 (33%) subjects, nausea in 2 (17%) subjects, constipation in 2 (17%) subjects, and diarrhea in 1 (8%) subject.
Frequency: 1 affected / 6 at risk